ClinConnect ClinConnect Logo
Search / Trial NCT06638528

Effects of Walking Apnea At High Lung Volume on Hypoalgesia

Launched by UNIVERSIDAD REY JUAN CARLOS · Oct 9, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a specific type of breathing exercise, called walking apnea at high lung volume, affects pain sensitivity in healthy adults. The researchers want to see if taking short breaks from walking while holding your breath can help reduce pain, known as hypoalgesia. They are also looking at how this exercise impacts heart and lung function during the activity.

To participate in the trial, you need to be between 18 and 64 years old and in good health, meaning you shouldn't have any major health issues like heart or lung diseases. If you have a history of certain medical conditions, are pregnant, or are currently taking medication, you won't be eligible to join. Participants will engage in a 6-minute training session and will be monitored for their heart and breathing responses, so they can expect a supportive environment focused on their health and safety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Asymptomatic subjects aged between 18 and 64 years.
  • Exclusion Criteria:
  • Cardiovascular, respiratory, metabolic, neurological or osteomuscular signs or pathologies.
  • History of epilepsy.
  • Pregnant
  • Pharmacological treatment.
  • Participants who present any type of pain on the day of the measurements or who have frequently suffered pain during the previous 4 weeks.

About Universidad Rey Juan Carlos

Universidad Rey Juan Carlos (URJC) is a prominent academic institution located in Madrid, Spain, dedicated to advancing knowledge and research in various fields, including health sciences. With a commitment to innovation and excellence, URJC actively engages in clinical trials aimed at improving patient care and outcomes. The university's multidisciplinary approach fosters collaboration among researchers, clinicians, and industry partners, ensuring that its clinical research is grounded in scientific rigor and ethical standards. Through its robust infrastructure and expertise, Universidad Rey Juan Carlos is poised to contribute significantly to the advancement of medical research and the development of novel therapeutic interventions.

Locations

Madrid, , Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported